Equine piroplasmosis (EP) has not been considered indigenous in The Netherlands.
Introduction
Equine piroplasmosis (EP) is an important tick-borne protozoan disease that poses a serious threat to the horse industry and has important implications for the international movement of horses (Friedhoff et al., 1990) . The disease is caused by Babesia caballi and/or Theileria equi and is endemic in many tropical and subtropical areas (de Waal, 1992) . Since EP can occur in any region or environment where horses are exposed to vector ticks, horses in countries with a moderate climate can also be affected (Mehlhorn and Schein, 1998) . Relocation of carrier horses and infected ticks by international transport is a potential means of spreading the infection. The expansion of permissive tick vectors to hitherto non-endemic countries and the changes in habitat for both ticks and wildlife species as a result of climate change are other promoting factors (Sreter et al., 2005) . Ticks capable of acting as vectors for B. caballi and T. equi include those belonging to the genera Dermacentor, Hyalomma and Rhipicephalus (Uilenberg, 2006) .
According to the World Organisation for Animal Health (OIE) Manual (2010), The
Netherlands is considered free of autochthonous EP. However, the recent discovery of resident Dermacentor reticulatus populations (Nijhof et al., 2007) , combined with a subclinical B. caballi infection in a horse that had never left The Netherlands, prompted investigation of the actual prevalence of B. caballi and T. equi.
The aims of this study were to determine the prevalence of T. equi and B. caballi infections in horses in the area where the initial subclinical B. caballi infection occurred. In addition, we report the first confirmed acute autochthonous T. equi infections in indigenous ponies in The Netherlands.
Materials and methods

Case that prompted the study
The subclinical case that prompted the present study involved a 12-year-old Dutch Warmblood gelding presented to a referral clinic (DAP Bodegraven) for treatment of a massive tick infestation with extensive skin swelling following a ride in a forest on Schouwen-Duiveland (an island in the Province of Zeeland) in July 2009. The skin swelling was treated with a combination of a non-steroidal anti-inflammatory drug (flunixin meglumine, 1 mg/kg body weight [BW] intravenously [IV] ) and an antibiotic (oxytetracycline, 6.6 mg/kg BW, every 12 h IV for 7 days). The infestation of the limbs and ventral abdomen was so extensive that an acaricidal fluid (fipronil, Frontline, Merial) was sprayed on the affected areas. Most ticks were identified as engorged Ixodes ricinus nymphs, but there were simply too many ticks to identify all of them. Thus, species other than I. ricinus, which is not considered a vector of EP, may have been present. 
Sample collection
To detect a 1% incidence of infection with a certainty of 95% in a population estimated at 5 000-10 000 horses living in the 'high risk area' where the subclinical EP had been diagnosed, it was calculated that a minimum of 300 animals needed to be tested (Win Episcope, Risk-based sampling) ( Fig. 1 ). For this we used the formula:
where n = required sample size; α = 1 -confidence level (0.05); D = estimated minimum number of diseased animals in population; N = population size) (Dohoo et al., 2010) .
Between May and August 2010, jugular vein blood samples were collected into EDTA and serum tubes from 300 horses. Apparently healthy horses that were either privately owned or owned by a riding school were selected and sampled based on (1) the owner's willingness to cooperate, (2) the horse having lived in the area for at least 1 year and (3) the horse having access to pasture and/or being used for outdoor recreation.
Blood sampling of client-owned horses for diagnostic purposes is not considered animal experimentation under Dutch law; this was confirmed by Utrecht University's Animal Ethical
Committee for this specific study. Since it is often difficult to establish whether horses are truly autochthonous and have not travelled to another country at some point in their lives, it was decided to only attempt to trace the full background and movements of horses that were EP positive.
Haematology
Haematology was used to determine whether (in the group of 300 apparently healthy horses included in the survey) positivity for piroplasmosis had an influence on packed cell volume, white blood cell count, or thrombocyte count. All 300 EDTA samples were therefore analysed on the day of sampling using a Medonic Haematology Analyzer.
IFAT
Samples were screened for antibodies against T. equi and B. caballi using a standard IFAT protocol, as described by Madden and Holbrook (1968) . Bound equine IgG antibodies were detected using a fluorescein isothiocyanate-conjugated rabbit anti-horse secondary antibody (RAHo/IgG(H + L)FITC; Nordic Immunology). All samples were screened at a starting dilution of 1:80 in phosphate-buffered saline (pH 7.2), as described in the manufacturer's protocol.
Positive samples were subsequently analysed to determine the titre. Antibody titres were categorized into three groups: 1:80, 1:160 and >1:320. Any sample showing fluorescence at a dilution of ≥1:160 was considered positive. Positive and negative controls were included in each run.
DNA extraction
DNA was extracted from EDTA blood using the QIAamp DNA mini kit (Qiagen) as described in the manufacturer's protocol.
PCR amplification and reverse line blot (RLB) hybridization
The primers RLB-F2 (5′-GAC ACA GGG AGG TAG TGA CAA G-3′) and RLB-R2 (5′-biotin-CTA AGA ATT TCA CCT CTG ACA GT-3′) were used to amplify the V4 hyper-variable region of the piroplasmid 18S rRNA gene, and the PCR products were subsequently subjected to RLB hybridization as described previously (Nijhof et al., 2005) . Positive and negative controls were included in each run.
Clinical EP cases
Two pregnant ponies (A and B; aged 18 and 20 years, respectively), housed together and acquired 2 and 5 months previously (from different parts of The Netherlands) for the purpose of commercial plasma collection, were presented to a local practitioner with signs of lethargy, anorexia and pyrexia. Blood was collected in EDTA and serum tubes. Because the acute signs suggested EP, the samples were analysed for the presence of T. equi and B. caballi by microscopic examination of stained thin blood smears and by serology (IFAT) and molecular testing (PCR-RLB). Blood collected (and stored with EDTA at 4 °C) from pony B approximately 7 days prior to clinical signs was also tested. Once piroplasmosis was confirmed, the ponies received a blood transfusion, and treatment with imidocarb dipropionate (4 mg/kg BW every 72 h intramuscularly) was recommended.
Statistical evaluation
All data are given as absolute numbers, as percentages or as means ± standard deviations.
Statistical evaluation of the blood parameters was performed using a two-sample t test (software used: R, A Language and Environment for Statistical Computing, R Development Core Team R Foundation for Statistical Computing, 2010). P < 0.05 was considered to be statistically significant.
Results
Survey
Of the 300 horses included in the survey, 12 (4%) tested seropositive for EP (Table 2) . Of these, nine (3%) were seropositive (titre ≥1:160) for B. caballi and three (1%) were positive for both B. caballi and T. equi. In addition five horses (1.6%) tested positive for T. equi DNA, although only three had T. equi antibody titres (Table 2) . Babesia caballi DNA was not detected by PCR-RLB, but one horse (horse 123) was positive for the Babesia catch-all genus probe used in conjunction with a B. bovis probe (not included in Table 2 ). In samples that were positive for EP, the platelet count was lower than in the negative samples (P = 0.025; Table 3 ). 
Clinical cases
Haematological assessment of the two ponies (A and B) that presented with signs suggesting acute piroplasmosis revealed marked anaemia in both cases and a marked thrombocytopenia for pony A (Table 1 ). Microscopic examination of thin blood smears revealed round to pear-shaped bodies and an occasional 'Maltese cross' inside the red blood cells, indicating T. equi organisms (Fig. 2) . No antibodies to T. equi were detected and PCR-RLB was negative for T. equi in blood collected from pony B 1 week before clinical signs were apparent. However, during the period in which the ponies showed clinical signs, both T. equi antibodies and DNA (via PCR-RLB) were detected in blood from both animals ( Table 1) .
Table 3
Haematological parameters for 300 randomly selected horses divided by piroplasma status (positive or negative horses). Values are shown as means (± standard deviation). prophylactic administration of oxytetracycline in an attempt to curb the potential sequelae of the severe tick infestation; oxytetracycline has been shown to exhibit an inhibitory effect on T. equi sporozoites cultured in vitro and on Babesia divergens replication in cattle (Taylor et al., 1986 ) if administered early during infection (Zweygarth et al., 1984) .
Fig. 2.
Theileria equi parasites in red blood cells as visualized by Giemsa staining of a thin blood smear from pony A.
With respect to the acute T. equi cases described in this study, the owner stated that the two ponies had been on the premises for only 2 months (pony B) and 5 months (pony A), respectively, having been purchased from different areas of The Netherlands (Provinces of Gelderland and Friesland, respectively). Both ponies showed clinical signs suggestive of acute piroplasmosis. Importantly, while specific antibodies were not detected in pony B at first presentation, a T. equi titre of 1:320 was detected by IFAT 7 days later, indicating that pony B had acquired the infection at its new location in The Netherlands. Pony A showed clinical signs indicative of piroplasmosis 1 week before pony B. Unfortunately, no initial blood sample was available from pony A.
Both ponies were pregnant and used for commercial plasma collection so it is possible that the immunosuppressant effects of pregnancy or the stress of pregnancy and/or plasma collection activated a dormant infection leading to clinical disease. In this respect, it cannot be excluded that pony A was a T. equi carrier and experienced reactivation, after which it became a reservoir for transmission to pony B, either via a tick vector or iatrogenically (in this case as a result of blood collection procedures). The latter mode of transmission is unlikely, however, because new disposable catheters were used for each horse as a standard procedure. It is therefore possible that both ponies were infected via D. reticulatus ticks present in the surrounding environment. Dermacentor reticulatus ticks are distributed in Europe by animals travelling to and from endemic areas, with the majority originating from Southern Europe, where D. reticulatus is well established (Estrada-Pena et al., 2004) . In theory, several wildlife species including migrating birds could also play a role in tick distribution.
The results of our survey show that although piroplasma infections are found in horses imported into The Netherlands, the prevalence of seropositive or DNA positive horses, in both the indigenous and imported horse populations, is still relatively low. Most studies on the prevalence of T. equi and B. caballi have been conducted in Southern Europe where the infection is endemic (Camacho et al., 2005; Leblond et al., 2005; Kouam et al., 2010; Moretti et al., 2010) .
Little information is available on the prevalence and possible emergence of EP in North Western Europe, with published data only available from Germany and Switzerland where seroprevalences of 5.6% and 4.4% T. equi and 1.2% and 1.5% B. caballi, respectively, have been reported (Boch, 1985; Sigg et al., 2010) . Several clinical cases of EP have been recorded in Belgium (Mantran et al., 2004) but no information is available on the seroprevalence of EP in that horse population.
The overall seroprevalence in the present study is of a similar magnitude to those reported in Switzerland and Germany. Furthermore, the seroprevalence for B. caballi in the current study was higher than for T. equi, which is also in line with both other reports. While antibody titres indicate past infections of unknown age, positive PCR-RLB results demonstrate current active parasite infestation. Positive PCR-RLB results for T. equi in the peripheral blood of two indigenous and three imported horses are reasons for concern with regard to the spread of this pathogen in The Netherlands; horses are considered to be the primary reservoir for T. equi (Allsopp et al., 2007; Ueti et al., 2008) and established populations of D. reticulatus are now present in The Netherlands (Nijhof et al., 2007) .
Two of the five horses that tested positive for T. equi in the PCR-RLB did not have an antibody titre when examined by IFAT, and it is therefore likely that they had been infected relatively recently. An interesting finding in this survey was the detection of B. bovis DNA via PCR-RLB performed on blood collected from horse 123. This particular horse was apparently healthy, and its haematological parameters were within the normal range. Even though it has been reported once previously (Criado et al., 2006) , the significance of B. bovis DNA in a horse is unclear.
may include a reduced red blood cell count, platelet count and haemoglobin concentration (de Waal, 1992) . The significantly lower platelet count in the piroplasmosis positive horses in the present study is therefore consistent with (sub)clinical piroplasmosis.
Conclusions
This study confirmed that autochthonous EP occurs in The Netherlands, albeit sporadically. With the apparent establishment of indigenous D. reticulatus populations (Nijhof et al., 2007) and unrestricted importation of horses from piroplasmosis endemic areas, the chance of encountering clinical EP cases in The Netherlands is likely to increase and veterinarians should therefore consider this disease in the differential diagnosis for anaemic horses, even if the animals have never left the country.
